![]() |
|||
![]() ![]() ![]() |
Parathyroid Adenoma | ||
![]() |
|
![]() |
|
|||
![]() |
Related narrative: Parathyroid Adenoma
| |||
![]() |
Diagnosis | |||
![]() |
| Labs: | ||
![]() |
| Serum calcium (marked elevation suggestive carcinoma) | ||
![]() |
| Elevated 24 hour urinary calcium (rule out FHH) | ||
![]() |
| Intact PTH assay | ||
![]() |
| Radiology: | ||
![]() |
| Xrays subperiosteal bone reabsorption, osteitis fibrosa cystica (bone reabsorption, cysts, brown tumors) found < 10% patients | ||
![]() |
| Localization studies (clearly indicated for recurrent or persistent disease) | ||
![]() |
| 99m Tc sestamibi sensitivity 90%, also effective at localization (89%) and differentiation between adenoma and hyperplasia (83%) | ||
![]() |
| Ultrasound sensitivity unoperated patients of 70-80%, 40% after operation | ||
![]() |
| CT/MRI reoperative accuracy of 50-80% | ||
![]() |
| Venous sampling | ||
![]() |
||||
![]() |
Non-Operative Therapy | |||
![]() |
| Hypercalcemic crisis muscular weakness, nausea and vomiting, fatigue, drowsiness, and confusion, serum Ca > 14 | ||
![]() |
| treatment with NS followed by furosamide diuresis, calcitonin, steroids, mithramycin, orthophosphate | ||
![]() |
| Management with medications (as above) only for those with extensive surgical risk | ||
![]() |
||||
![]() |
Operative Approach | |||
![]() |
| Parathyroidectomy in both symptomatic and asymptomatic patients results in normalization of serum values and increased bone density | ||
![]() |
| Adenoma | ||
![]() |
| one or more enlarged gland | ||
![]() |
| one enlarged gland resect | ||
![]() |
| two or more enlarged glands (resect with biopsy normal gland to rule out hyperplasia) | ||
![]() |
| Hyperplasia | ||
![]() |
| Non-familial | ||
![]() |
| radical subtotal (three and one-half-gland) parathyroidectomy | ||
![]() |
| pare remnant first to ensure viability | ||
![]() |
| 0 - 16% recurrence rate | ||
![]() |
| Familial | ||
![]() |
| total parathyroidectomy and heterotopic autotransplantation (non-dominant forearm) with parathyroid cyropreservation | ||
![]() |
| No enlarged parathyroid gland exploration of the upper mediastinum, retroesophageal area, carotid sheaths, and thyroid gland. If negative then close and proceed to localization studies (i.e., sestamibi) with directed re-exploration and possible median sternotomy | ||
![]() |
| Minimally invasive radioguided parathyroidectomy | ||
![]() |
| Preoperative technetium 99m-labeled sestamibi scanning | ||
![]() |
| Gamma counter directed minimal incision and dissection | ||
![]() |
| ex vivo radiation measurements resected parathyroid tissue | ||
![]() |
| intraoperative PTH assay | ||
![]() |
||||
![]() |
Complications | |||
![]() |
| Postoperative hypoparathyroidism | ||
![]() |
| serum calcium level reaches its lowest level in 48 to 72 hours and returns to normal 2 to 3 days | ||
![]() |
| treat if Ca < 7 or patient symptomatic (numbness and tingling in the circumoral area, the fingers, and the toes, anxiety, depression, tetany positive Chvostek's or Trousseau's sign) | ||
![]() |
| Recurrent laryngeal nerve injury (1-2% rate) | ||
![]() |
| Postoperative hematoma | ||
![]() |
| bedside exploration if symptomatic | ||
![]() |
||||
![]() |
References
Johnston LB J Clin Endocrinol Metab 1996 Jan; 81(1): 346-52 Silverberg SJ N Engl J Med 1999 Oct 21; 341(17): 1249-55 Norman J, Chheda H Surgery 122:998-1004, 1997 Textbook of surgery: the biological basis of modern surgical practice. 15th ed. / [edited by] David C. Sabiston, Jr.; editor for basic surgical science, H. Kim Lyerly
|